Ageing - Pipeline Review, H2 2015

1
Ageing - Pipeline Review, H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Ageing
• The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• The report reviews key players involved in the
  therapeutics development for Ageing and enlists
  all their major and minor projects
• The report summarizes all the dormant and
  discontinued pipeline projects
• A review of the Ageing products under development
  by companies and universities/research institutes
  based on information derived from company and
  industry-specific sources
• Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• A detailed assessment of monotherapy and
  combination therapy pipeline projects
• Coverage of the Ageing pipeline on the basis of
  target, MoA, route of administration and molecule
  type
• Latest news and deals relating related to
  pipeline products
• Read More At http//www.researchbeam.com/ageing-
  pipeline-review-h2-2015-market

3


Table of Content
List of Figures Number of Products under
Development for Ageing, H2 2015 8 Number of
Products under Development for Ageing -
Comparative Analysis, H2 2015 9 Number of
Products under Development by Companies, H2 2015
10 Number of Products under Investigation by
Universities/Institutes, H2 2015 11 Comparative
Analysis by Early Stage Products, H2 2015
13 Assessment by Monotherapy Products, H2 2015
23 Number of Products by Targets, H2 2015
24 Number of Products by Stage and Targets, H2
2015 24 Number of Products by Mechanism of
Actions, H2 2015 26 Number of Products by Stage
and Mechanism of Actions, H2 2015 26 Number of
Products by Routes of Administration, H2 2015
28 Number of Products by Stage and Routes of
Administration, H2 2015 28 Number of Products by
Molecule Types, H2 2015 30 Number of Products by
Stage and Molecule Types, H2 2015 30
4


Report Overview
Reasons to buy Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage Develop strategic initiatives by
understanding the focus areas of leading
companies Identify and understand important and
diverse types of therapeutics under development
for Ageing Plan mergers and acquisitions
effectively by identifying key players of the
most promising pipeline Devise corrective
measures for pipeline projects by understanding
Ageing pipeline depth and focus of Indication
therapeutics Develop and design in-licensing and
out-licensing strategies by identifying
prospective partners with the most attractive
projects to enhance and expand business potential
and Scope Modify the therapeutic portfolio by
identifying discontinued projects and
understanding the factors that drove them from
pipeline Enquire At http//www.researchbeam.co
m/ageing-pipeline-review-h2-2015-market/enquire-ab
out-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/ageing-pipeline-review
-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com